Vlado Perkovic's Publications

About Vlado Perkovic's Publications

Board Member
  • MBBS,
  • PhD,
  • FASN,
  • FRACP

  • THE QUALITY OF LIFE IMPROVEMENTS ASSOCIATED WITH EXTENDED HOURS DIALYSIS ARE CONSISTENT ACROSS SUBGROUPS

    Date published:

  • Effects of the DPP-4 Inhibitor Linagliptin on Heart Failure Outcomes in Patients With Type 2 Diabetes and Cardio-Renal Disease in CARMELINA

    Date published:

  • Canagliflozin and cardiovascular outcomes in patients with chronic kidney disease

    Date published:

  • Meta-Analyses of Blood Pressure Lowering Trials and the Blood Pressure Lowering Treatment Trialists’ Collaboration

    Hypertension: A Companion to Braunwald's Heart Disease Date published:

  • Meta-Analyses of Blood Pressure Lowering Trials and the Blood Pressure Lowering Treatment Trialists’ Collaboration

    Hypertension: A Companion to Braunwald's Heart Disease Date published:

  • Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes

    New England Journal of Medicine Date published:

  • Changes in Albuminuria and the Risk of Major Clinical Outcomes in Diabetes: Results From ADVANCE-ON

    Diabetes Care Date published:

  • Action plan for optimizing the design of clinical trials in chronic kidney disease

    Kidney International Supplements Date published:

  • Closing the gap between evidence and practice in chronic kidney disease

    Kidney International Supplements Date published:

  • Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy

    The Lancet Date published:

  • Comparative effectiveness and tolerance of immunosuppressive treatments for idiopathic membranous nephropathy: A network meta-analysis

    PLOS ONE Date published:

  • Are SGLT2 Inhibitors Ready for Prime Time for CKD?

    Clinical Journal of the American Society of Nephrology Date published:

  • Measures of chronic kidney disease and risk of incident peripheral artery disease: a collaborative meta-analysis of individual participant data

    The Lancet Diabetes & Endocrinology Date published:

  • Longitudinal Assessment of the Effect of Atrasentan on Thoracic Bioimpedance in Diabetic Nephropathy: A Randomized, Double-Blind, Placebo-Controlled Trial

    Drugs in R&D Date published:

  • Composite Primary End Points in Cardiovascular Outcomes Trials Involving Type 2 Diabetes Patients: Should Unstable Angina Be Included in the Primary End Point?

    Diabetes Care Date published:

  • Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes

    New England Journal of Medicine Date published: